• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Embellence Group: Comps dictate Q2 performance - ABG

EMBELLEksterne analyser25.06.2026, 08.56

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier

Download analyse (PDF)
* We forecast net sales of SEK 191m in Q2'26e
* DTC could weigh on Q2 EBITA, -7% y-o-y at SEK 24m
* We reiterate our SEK 36-43 fair value range


We forecast EBITA -6% y-o-y in Q2 on elevated DTC efforts

We expect sequentially tougher comps to lead to a deceleration for Embellence Group. Compared to 3.5% organic growth in Q1, we expect deceleration to flat growth in Q2 for net sales of SEK 191m. By segment, we expect the soft spell in Cole & Son to continue from Q1, following changes to the distributíon setup, and we forecast -6% organic growth for this segment. We also forecast a clear organic decline, -19%, for Artscape, versus the same quarter last year in which it launched a product line with a large customer. On the other hand, we expect Pappelina to continue to perform well after the DTC platform update (+20% org. growth) and its External Manufacturing segment to remain at the net sales level it reached in Q1, suggesting 16% growth. We expect stable gross margins to continue from Q1, and a slightly lower absolute opex level as Q1 contained more costs for trade fairs than is typical in Q2. All in all, we forecast adj. EBITA of SEK 24m, -7% y-o-y, as the group ramps up its DTC efforts.


Shift to DTC weighs on '26e EBITA growth

The transition to DTC is likely to keep weighing on profitability through a higher opex ratio: we forecast a 45% opex ratio for 2026 compared to 44% for 2025 and 42% for 2024. As such, we believe Embellence Group's EBITA growth for '26e could be muted at 1%.


We reiterate our fair value range of SEK 36-43

As we make only minor estimate revisions, we reiterate our fair value range of SEK 36-43. The share is currently trading at 7.5/5.2x EV/EBITA '26e/'28e, compared to a historical trading range of 7x-8x NTM and a Swedish peer group of home improvement companies at a median 11x/6.5x '26e/'28e. We estimate a 11-14% FCF yield '26e-'28e, and a dividend yield of 5-5.7% for the same years.